New anesthesia drug checked for heart risks in healthy volunteers
NCT ID NCT06795204
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed early-stage study looked at whether a single dose of HSK3486, an anesthesia drug, changes the heart's electrical activity in 48 healthy adults aged 18 to 45. The main goal was to measure any effects on heart repolarization (QTc interval) and check for side effects. No treatment was given for any disease, so this trial was purely about safety and understanding the drug's heart effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA; ADVERSE EFFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Gobroad Boren Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable heart monitor works during scans, study finds
- Blood test may reveal hidden heart damage in AFib patients
- Smart patches could save hearts: hospital trial tests continuous monitoring
- Smartwatch and ring take on the 12-Lead ECG in heart rhythm showdown
- New heart monitor could make ablation safer
- Armband could replace holter monitors for heart arrhythmia detection